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Abstract 
Transcatheter atrial septal defect (ASD) device closure has gained increasing popularity over 
the past decades due to shorter hospital stay and the absence of skin scars. However, 
concern about the seriousness of device-related complications is accumulating. We report a 
case of device fracture in a young asymptomatic woman almost 4 years after percutaneous 
secundum ASD closure, resulting in mitral valve perforation. Subsequently, elective surgical 
removal of the device and mitral valve reconstruction was performed. This case 
demonstrates that complications from transcatheter ASD closure may even occur late after 
implantation.  
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Over the past decades, transcatheter device closure has become first choice in the treatment 
of secundum atrial septal defects (ASD) if morphology is feasible [1]. Although many studies 
have shown high rates of successful closure, there is accumulating concern about the 
seriousness of device-related complications even years after device deployment, including 
fatalities or serious events requiring salvage surgery [2-4]. This supports the 
recommendation that such patients should remain under permanent surveillance to observe 
potentially serious long-term complications [3]. 
Here, we report an ATRIASEPT II device (Version 2008, Cardia Inc., Eagan, MN, USA) 
fracture almost 4 years after percutaneous secundum ASD closure, associated with 
subsequent mitral valve perforation and regurgitation that required surgical repair. For the 
review of clinical records and the publication of this case, an informed consent was obtained 
from the patient. 
 
 
A 19-year-old female underwent endovascular secundum ASD closure at the age of 16 
years. Closure was successfully performed using a 22mm ATRIASEPT II occluder (version 
2008, Cardia Inc., Eagan, MN, USA), a double-disk-device offering a low-profile conformation 
to the septum.  
At routine control almost 4 years after implantation, transthoracic echocardiography revealed 
a fractured arm of the ATRIASEPT II device. Since the fracture occurred in one of the inferior 
arms, the strut protruded in antero-inferior direction and came into direct contact with the 
anterior leaflet of the mitral valve (segment A2) (Fig. 1a, 1b). Echocardiography showed the 
strut in the A2 segment of the mitral valve causing a minimal mitral insufficiency (1/4) in the 
posteromedial commissure at the basis of the posteromedial segment P3 (Fig. 1c). During 
ventricular systole, the anterior leaflet folded around the strut. The device was still effective in 
occluding the former ASD without residual shunt. There were no other pathological findings 
in echocardiography, the other valves as well as right and left (EF 74%) ventricular pump 
function were normal. 
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Owing to the lesions of the mitral valve, elective surgical removal of the device was indicated. 
Following midaxillary thoracotomy in the 4th intercostal space, total cardiopulmonary bypass 
was set up through the femoral vessels. The right atrium was opened and the device was 
found to be only partially endothelialized. Due to the proximity to the atrioventricular node, 
device removal was a delicate process. After the device was removed and the left atrium was 
inspected through the open ASD, a remaining strut was identified perforating the anterior 
leaflet of the mitral valve (Fig. 2). The strut was removed and the two mitral valve 
perforations, one in the anterior (A2) and one in the posterior (P3) leaflet, were repaired by 
direct suture. The septum was closed using an autologous pericardial patch. After weaning 
from bypass, echocardiographic reassessment showed a sufficient patch closure of the ASD 
without residual shunt and a good mitral valve function with minimal regurgitation towards the 
posteromedial commissure. The postoperative course was uneventful without the 
development of an atrioventricular block. The patient was discharged 4 days after surgery 
and recovered rapidly. 
 
 
Comment 
Our case demonstrates a fracture of an ATRIASEPT II (version 2008, Cardia Inc., Eagan, 
MN, USA) septal occluder device with subsequent mitral valve perforation requiring surgical 
intervention. While in the case presented here the fracture was located in a favorable inferior 
position, resulting in asymptomatic mitral valve perforation, reports of other cases of 
ATRIASEPT device fractures show possible fatal consequences such as aortic root 
perforation [5,6]. In contrast to its precursors, the ATRIASEPT II device presents an 
improved left atrial sail. Six wires in parabolic shape make up the skeleton for a circular sail 
and eliminate pointed arm tips while preventing a prolapse of the sail. 
However, in the case presented here, it was exactly one of the parabolic wires that fractured, 
leading to the perforations of the mitral valve. As the strut was made of nitinol, a metal known 
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for its ability to return to its “memory shape”, the tension inside the occluder device was 
maintained over the years and, once fractured, caused a protrusion of the arm towards the 
mitral valve.  
The initial cause of the strut fracture is difficult to identify. Physical strain on the device would 
be a plausible explanation if the fracture was located near the aortic root and the device 
would have shown a protrusion into or a splaying around the aortic root. But since the 
fracture was located inferiorly, strain-induced fracture is less likely. Assuming that the device 
remained in correct position, it is more likely that the constant tension within the parabolic 
arms of the device eventually resulted in a fracture. The partial endothelization of the device 
certainly contributed to the fact that the strut was able to unfold freely. Remarkably, all 
ATRIASEPT device fractures reported in the literature occurred late between 3 months and 4 
years after implantation, similar to the case reported here, rather than directly after 
intervention [5,6]. 
 
Conclusion 
This case report displays that endovascular ASD closure with the ATRIASEPT II occluder 
may result in device fracture with associated perforation of surrounding cardiac structures. 
The possibly fatal complications may occur late after implantation, even when the device is in 
correct position. Close monitoring is recommended for fractures of the parabolic left atrial 
struts and for subsequent perforations which might trigger endocarditis and thromboembolic 
events. The case presented here also demonstrates that even 4 years after implantation 
device endothelization may still be incomplete.  
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Figure Legends 
Figure 1: (a) Transthoracic echocardiography demonstrating the fractured strut protruding in 
antero-inferior direction and coming into contact with the anterior leaflet of the mitral valve. 
(b) Transthoracic 3D echocardiography displaying the fractured ATRIASEPT II septal 
occluder in loco typico. The fractured arm is protruding anteroinferiorly towards the valvular 
plane and coming into contact with the anterior leaflet of the mitral valve. (c) Duplex 
echocardiography during systole showing minimal mitral insufficiency.  
Asterisk: Fractured arm of the device, De: ATRIASEPT II Device, LA: Left Atrium. 
 
Figure 2: Intraoperative view of the ATRIASEPT II device after left atriotomy. The fractured 
and only partly endothelialized left atrial strut of the device is shown perforating the anterior 
leaflet (A2) of the mitral valve.  
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